Global Next Generation Pipettes Market

Next Generation Pipettes Comprehensive Study by Type (Automatic, Semiautomatic, Manual), Application (Biological Field, Chemical Field, Medical Field), Distribution Channel (Online, Offline), End-User (Biotechnological Companies, Hospitals, Diagnostic Centers, Research Laboratories, Others) Players and Region - Global Market Outlook to 2026

Next Generation Pipettes Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Next Generation Pipettes Market Scope?
Pipetting systems, also known as liquid-handling robots, are instruments that rapidly determine the precise volume of regent and specimen. A motion mechanism that moves heads with nozzles and plates, as well as a controller to operate the system, are included in these products. Pipetting devices are used in biochemical laboratories and pharmaceutical R&D for automation. The pipetting head, user interface, working field, and waste container are the four essential structural components of most pipetting systems. A pipette is a mechanical device for moving liquids. A single-channel or multi-channel pipette head is available. The user interface allows the device and the user to communicate through a touchscreen or a computer. Water is dispensed via the working field, and the pipetting head travels upwards. It is made up of holders that house the liquid containers that are being processed. There is also a waste bin that holds disposable tips that are used by the machine to dispose of washing buffer or excess liquid.

Influencing Trend:
Advancement in Product like Robotics Pipetting Systems

Market Growth Drivers:
Rising Markets in the Diagnostic and Laboratory Sectors and Growing Funding for Drug and Biotechnology Research Activities

Challenges:
Lack of Skilled and Qualified Healthcare Professionals

Restraints:
High Cost Related to Next Generation Pipettes

Opportunities:
Rising Investment on the R&D by Biotechnology Firms, Increasing Number of Pharmaceuticals and Biotechnology Firms and Continuous improvements and New Technologies in Pipetting Devices have Increased their Uses in Bioinformatics

The Next Generation Pipettes market study is being classified by Type (Automatic, Semiautomatic and Manual), by Application and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Next Generation Pipettes market throughout the predicted period.

Danaher Corporation (United States), Eppendorf AG (Germany), Tecan Group Ltd. (Switzerland), Gardner Denver Medical (Germany), Mettler-Toledo International Inc. (United States), Hamilton Company (United States), PerkinElmer, Inc. (United States), Sartorius AG (Germany), Gilson, Inc. (United States) and Agilent Technologies, Inc. (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Next Generation Pipettes market by Type, Application and Region.

On the basis of geography, the market of Next Generation Pipettes has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In July - 2020, Gilson Releases Two New Pipetman Pipette Models and In March 2021, Eppendorf introduces connected electronic pipettes. Eppendorf has developed the brand new VisioNize pipette manager. The system is ideal for scientists who manage a high workload and require many intricate pipetting steps.


Key Target Audience
Manufacturers of Next Generation Pipettes, Suppliers of Next Generation Pipettes, Wholesalers, Distributors and Retailers of Next Generation Pipettes, End-Use Industry and Others

Next Generation Pipettes Market Study: Important Years
AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Next Generation Pipettes Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Next Generation Pipettes industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Automatic
  • Semiautomatic
  • Manual
By Application
  • Biological Field
  • Chemical Field
  • Medical Field
By Distribution Channel
  • Online
  • Offline

By End-User
  • Biotechnological Companies
  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Markets in the Diagnostic and Laboratory Sectors
      • 3.2.2. Growing Funding for Drug and Biotechnology Research Activities
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled and Qualified Healthcare Professionals
    • 3.4. Market Trends
      • 3.4.1. Advancement in Product like Robotics Pipetting Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Next Generation Pipettes, by Type, Application, Distribution Channel, End-User and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Next Generation Pipettes (Value)
      • 5.2.1. Global Next Generation Pipettes by: Type (Value)
        • 5.2.1.1. Automatic
        • 5.2.1.2. Semiautomatic
        • 5.2.1.3. Manual
      • 5.2.2. Global Next Generation Pipettes by: Application (Value)
        • 5.2.2.1. Biological Field
        • 5.2.2.2. Chemical Field
        • 5.2.2.3. Medical Field
      • 5.2.3. Global Next Generation Pipettes by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Next Generation Pipettes by: End-User (Value)
        • 5.2.4.1. Biotechnological Companies
        • 5.2.4.2. Hospitals
        • 5.2.4.3. Diagnostic Centers
        • 5.2.4.4. Research Laboratories
        • 5.2.4.5. Others
      • 5.2.5. Global Next Generation Pipettes Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Next Generation Pipettes (Volume)
      • 5.3.1. Global Next Generation Pipettes by: Type (Volume)
        • 5.3.1.1. Automatic
        • 5.3.1.2. Semiautomatic
        • 5.3.1.3. Manual
      • 5.3.2. Global Next Generation Pipettes by: Application (Volume)
        • 5.3.2.1. Biological Field
        • 5.3.2.2. Chemical Field
        • 5.3.2.3. Medical Field
      • 5.3.3. Global Next Generation Pipettes by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Next Generation Pipettes by: End-User (Volume)
        • 5.3.4.1. Biotechnological Companies
        • 5.3.4.2. Hospitals
        • 5.3.4.3. Diagnostic Centers
        • 5.3.4.4. Research Laboratories
        • 5.3.4.5. Others
      • 5.3.5. Global Next Generation Pipettes Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Next Generation Pipettes (Price)
      • 5.4.1. Global Next Generation Pipettes by: Type (Price)
  • 6. Next Generation Pipettes: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Danaher Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Eppendorf AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Tecan Group Ltd. (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Gardner Denver Medical (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Mettler-Toledo International Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hamilton Company (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PerkinElmer, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sartorius AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Gilson, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Agilent Technologies, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Next Generation Pipettes Sale, by Type, Application, Distribution Channel, End-User and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Next Generation Pipettes (Value)
      • 7.2.1. Global Next Generation Pipettes by: Type (Value)
        • 7.2.1.1. Automatic
        • 7.2.1.2. Semiautomatic
        • 7.2.1.3. Manual
      • 7.2.2. Global Next Generation Pipettes by: Application (Value)
        • 7.2.2.1. Biological Field
        • 7.2.2.2. Chemical Field
        • 7.2.2.3. Medical Field
      • 7.2.3. Global Next Generation Pipettes by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Next Generation Pipettes by: End-User (Value)
        • 7.2.4.1. Biotechnological Companies
        • 7.2.4.2. Hospitals
        • 7.2.4.3. Diagnostic Centers
        • 7.2.4.4. Research Laboratories
        • 7.2.4.5. Others
      • 7.2.5. Global Next Generation Pipettes Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Next Generation Pipettes (Volume)
      • 7.3.1. Global Next Generation Pipettes by: Type (Volume)
        • 7.3.1.1. Automatic
        • 7.3.1.2. Semiautomatic
        • 7.3.1.3. Manual
      • 7.3.2. Global Next Generation Pipettes by: Application (Volume)
        • 7.3.2.1. Biological Field
        • 7.3.2.2. Chemical Field
        • 7.3.2.3. Medical Field
      • 7.3.3. Global Next Generation Pipettes by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Next Generation Pipettes by: End-User (Volume)
        • 7.3.4.1. Biotechnological Companies
        • 7.3.4.2. Hospitals
        • 7.3.4.3. Diagnostic Centers
        • 7.3.4.4. Research Laboratories
        • 7.3.4.5. Others
      • 7.3.5. Global Next Generation Pipettes Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Next Generation Pipettes (Price)
      • 7.4.1. Global Next Generation Pipettes by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Next Generation Pipettes: by Type(USD Million)
  • Table 2. Next Generation Pipettes Automatic , by Region USD Million (2016-2021)
  • Table 3. Next Generation Pipettes Semiautomatic , by Region USD Million (2016-2021)
  • Table 4. Next Generation Pipettes Manual , by Region USD Million (2016-2021)
  • Table 5. Next Generation Pipettes: by Application(USD Million)
  • Table 6. Next Generation Pipettes Biological Field , by Region USD Million (2016-2021)
  • Table 7. Next Generation Pipettes Chemical Field , by Region USD Million (2016-2021)
  • Table 8. Next Generation Pipettes Medical Field , by Region USD Million (2016-2021)
  • Table 9. Next Generation Pipettes: by Distribution Channel(USD Million)
  • Table 10. Next Generation Pipettes Online , by Region USD Million (2016-2021)
  • Table 11. Next Generation Pipettes Offline , by Region USD Million (2016-2021)
  • Table 12. Next Generation Pipettes: by End-User(USD Million)
  • Table 13. Next Generation Pipettes Biotechnological Companies , by Region USD Million (2016-2021)
  • Table 14. Next Generation Pipettes Hospitals , by Region USD Million (2016-2021)
  • Table 15. Next Generation Pipettes Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 16. Next Generation Pipettes Research Laboratories , by Region USD Million (2016-2021)
  • Table 17. Next Generation Pipettes Others , by Region USD Million (2016-2021)
  • Table 18. South America Next Generation Pipettes, by Country USD Million (2016-2021)
  • Table 19. South America Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 20. South America Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 21. South America Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 22. South America Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 23. Brazil Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 24. Brazil Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 25. Brazil Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 26. Brazil Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 27. Argentina Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 28. Argentina Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 29. Argentina Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 30. Argentina Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 31. Rest of South America Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 32. Rest of South America Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 33. Rest of South America Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 34. Rest of South America Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 35. Asia Pacific Next Generation Pipettes, by Country USD Million (2016-2021)
  • Table 36. Asia Pacific Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 37. Asia Pacific Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 38. Asia Pacific Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 39. Asia Pacific Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 40. China Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 41. China Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 42. China Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 43. China Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 44. Japan Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 45. Japan Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 46. Japan Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 47. Japan Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 48. India Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 49. India Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 50. India Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 51. India Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 52. South Korea Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 53. South Korea Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 54. South Korea Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 55. South Korea Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 56. Taiwan Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 57. Taiwan Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 58. Taiwan Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 59. Taiwan Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 60. Australia Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 61. Australia Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 62. Australia Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 63. Australia Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 68. Europe Next Generation Pipettes, by Country USD Million (2016-2021)
  • Table 69. Europe Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 70. Europe Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 71. Europe Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 72. Europe Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 73. Germany Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 74. Germany Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 75. Germany Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 76. Germany Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 77. France Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 78. France Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 79. France Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 80. France Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 81. Italy Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 82. Italy Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 83. Italy Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 84. Italy Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 85. United Kingdom Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 86. United Kingdom Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 87. United Kingdom Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 88. United Kingdom Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 89. Netherlands Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 90. Netherlands Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 91. Netherlands Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 92. Netherlands Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 93. Rest of Europe Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 94. Rest of Europe Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 95. Rest of Europe Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 96. Rest of Europe Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 97. MEA Next Generation Pipettes, by Country USD Million (2016-2021)
  • Table 98. MEA Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 99. MEA Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 100. MEA Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 101. MEA Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 102. Middle East Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 103. Middle East Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 104. Middle East Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 105. Middle East Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 106. Africa Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 107. Africa Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 108. Africa Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 109. Africa Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 110. North America Next Generation Pipettes, by Country USD Million (2016-2021)
  • Table 111. North America Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 112. North America Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 113. North America Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 114. North America Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 115. United States Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 116. United States Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 117. United States Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 118. United States Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 119. Canada Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 120. Canada Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 121. Canada Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 122. Canada Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 123. Mexico Next Generation Pipettes, by Type USD Million (2016-2021)
  • Table 124. Mexico Next Generation Pipettes, by Application USD Million (2016-2021)
  • Table 125. Mexico Next Generation Pipettes, by Distribution Channel USD Million (2016-2021)
  • Table 126. Mexico Next Generation Pipettes, by End-User USD Million (2016-2021)
  • Table 127. Next Generation Pipettes Sales: by Type(K Units)
  • Table 128. Next Generation Pipettes Sales Automatic , by Region K Units (2016-2021)
  • Table 129. Next Generation Pipettes Sales Semiautomatic , by Region K Units (2016-2021)
  • Table 130. Next Generation Pipettes Sales Manual , by Region K Units (2016-2021)
  • Table 131. Next Generation Pipettes Sales: by Application(K Units)
  • Table 132. Next Generation Pipettes Sales Biological Field , by Region K Units (2016-2021)
  • Table 133. Next Generation Pipettes Sales Chemical Field , by Region K Units (2016-2021)
  • Table 134. Next Generation Pipettes Sales Medical Field , by Region K Units (2016-2021)
  • Table 135. Next Generation Pipettes Sales: by Distribution Channel(K Units)
  • Table 136. Next Generation Pipettes Sales Online , by Region K Units (2016-2021)
  • Table 137. Next Generation Pipettes Sales Offline , by Region K Units (2016-2021)
  • Table 138. Next Generation Pipettes Sales: by End-User(K Units)
  • Table 139. Next Generation Pipettes Sales Biotechnological Companies , by Region K Units (2016-2021)
  • Table 140. Next Generation Pipettes Sales Hospitals , by Region K Units (2016-2021)
  • Table 141. Next Generation Pipettes Sales Diagnostic Centers , by Region K Units (2016-2021)
  • Table 142. Next Generation Pipettes Sales Research Laboratories , by Region K Units (2016-2021)
  • Table 143. Next Generation Pipettes Sales Others , by Region K Units (2016-2021)
  • Table 144. South America Next Generation Pipettes Sales, by Country K Units (2016-2021)
  • Table 145. South America Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 146. South America Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 147. South America Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 148. South America Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 149. Brazil Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 150. Brazil Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 151. Brazil Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 152. Brazil Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 153. Argentina Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 154. Argentina Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 155. Argentina Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 156. Argentina Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 157. Rest of South America Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 158. Rest of South America Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 159. Rest of South America Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 160. Rest of South America Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 161. Asia Pacific Next Generation Pipettes Sales, by Country K Units (2016-2021)
  • Table 162. Asia Pacific Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 163. Asia Pacific Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 164. Asia Pacific Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 165. Asia Pacific Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 166. China Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 167. China Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 168. China Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 169. China Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 170. Japan Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 171. Japan Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 172. Japan Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 173. Japan Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 174. India Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 175. India Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 176. India Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 177. India Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 178. South Korea Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 179. South Korea Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 180. South Korea Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 181. South Korea Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 182. Taiwan Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 183. Taiwan Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 184. Taiwan Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 185. Taiwan Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 186. Australia Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 187. Australia Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 188. Australia Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 189. Australia Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 190. Rest of Asia-Pacific Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 191. Rest of Asia-Pacific Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 192. Rest of Asia-Pacific Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 193. Rest of Asia-Pacific Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 194. Europe Next Generation Pipettes Sales, by Country K Units (2016-2021)
  • Table 195. Europe Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 196. Europe Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 197. Europe Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 198. Europe Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 199. Germany Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 200. Germany Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 201. Germany Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 202. Germany Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 203. France Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 204. France Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 205. France Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 206. France Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 207. Italy Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 208. Italy Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 209. Italy Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 210. Italy Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 211. United Kingdom Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 212. United Kingdom Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 213. United Kingdom Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 214. United Kingdom Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 215. Netherlands Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 216. Netherlands Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 217. Netherlands Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 218. Netherlands Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 219. Rest of Europe Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 220. Rest of Europe Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 221. Rest of Europe Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 222. Rest of Europe Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 223. MEA Next Generation Pipettes Sales, by Country K Units (2016-2021)
  • Table 224. MEA Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 225. MEA Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 226. MEA Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 227. MEA Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 228. Middle East Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 229. Middle East Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 230. Middle East Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 231. Middle East Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 232. Africa Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 233. Africa Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 234. Africa Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 235. Africa Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 236. North America Next Generation Pipettes Sales, by Country K Units (2016-2021)
  • Table 237. North America Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 238. North America Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 239. North America Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 240. North America Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 241. United States Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 242. United States Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 243. United States Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 244. United States Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 245. Canada Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 246. Canada Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 247. Canada Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 248. Canada Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 249. Mexico Next Generation Pipettes Sales, by Type K Units (2016-2021)
  • Table 250. Mexico Next Generation Pipettes Sales, by Application K Units (2016-2021)
  • Table 251. Mexico Next Generation Pipettes Sales, by Distribution Channel K Units (2016-2021)
  • Table 252. Mexico Next Generation Pipettes Sales, by End-User K Units (2016-2021)
  • Table 253. Next Generation Pipettes: by Type(USD/Units)
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Next Generation Pipettes: by Type(USD Million)
  • Table 265. Next Generation Pipettes Automatic , by Region USD Million (2022-2027)
  • Table 266. Next Generation Pipettes Semiautomatic , by Region USD Million (2022-2027)
  • Table 267. Next Generation Pipettes Manual , by Region USD Million (2022-2027)
  • Table 268. Next Generation Pipettes: by Application(USD Million)
  • Table 269. Next Generation Pipettes Biological Field , by Region USD Million (2022-2027)
  • Table 270. Next Generation Pipettes Chemical Field , by Region USD Million (2022-2027)
  • Table 271. Next Generation Pipettes Medical Field , by Region USD Million (2022-2027)
  • Table 272. Next Generation Pipettes: by Distribution Channel(USD Million)
  • Table 273. Next Generation Pipettes Online , by Region USD Million (2022-2027)
  • Table 274. Next Generation Pipettes Offline , by Region USD Million (2022-2027)
  • Table 275. Next Generation Pipettes: by End-User(USD Million)
  • Table 276. Next Generation Pipettes Biotechnological Companies , by Region USD Million (2022-2027)
  • Table 277. Next Generation Pipettes Hospitals , by Region USD Million (2022-2027)
  • Table 278. Next Generation Pipettes Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 279. Next Generation Pipettes Research Laboratories , by Region USD Million (2022-2027)
  • Table 280. Next Generation Pipettes Others , by Region USD Million (2022-2027)
  • Table 281. South America Next Generation Pipettes, by Country USD Million (2022-2027)
  • Table 282. South America Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 283. South America Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 284. South America Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 285. South America Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 286. Brazil Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 287. Brazil Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 288. Brazil Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 289. Brazil Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 290. Argentina Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 291. Argentina Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 292. Argentina Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 293. Argentina Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 294. Rest of South America Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 295. Rest of South America Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 296. Rest of South America Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 297. Rest of South America Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 298. Asia Pacific Next Generation Pipettes, by Country USD Million (2022-2027)
  • Table 299. Asia Pacific Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 300. Asia Pacific Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 301. Asia Pacific Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 302. Asia Pacific Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 303. China Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 304. China Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 305. China Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 306. China Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 307. Japan Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 308. Japan Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 309. Japan Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 310. Japan Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 311. India Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 312. India Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 313. India Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 314. India Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 315. South Korea Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 316. South Korea Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 317. South Korea Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 318. South Korea Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 319. Taiwan Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 320. Taiwan Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 321. Taiwan Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 322. Taiwan Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 323. Australia Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 324. Australia Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 325. Australia Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 326. Australia Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 327. Rest of Asia-Pacific Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 328. Rest of Asia-Pacific Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 329. Rest of Asia-Pacific Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 330. Rest of Asia-Pacific Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 331. Europe Next Generation Pipettes, by Country USD Million (2022-2027)
  • Table 332. Europe Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 333. Europe Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 334. Europe Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 335. Europe Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 336. Germany Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 337. Germany Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 338. Germany Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 339. Germany Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 340. France Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 341. France Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 342. France Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 343. France Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 344. Italy Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 345. Italy Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 346. Italy Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 347. Italy Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 348. United Kingdom Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 349. United Kingdom Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 350. United Kingdom Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 351. United Kingdom Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 352. Netherlands Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 353. Netherlands Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 354. Netherlands Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 355. Netherlands Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 356. Rest of Europe Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 357. Rest of Europe Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 358. Rest of Europe Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 359. Rest of Europe Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 360. MEA Next Generation Pipettes, by Country USD Million (2022-2027)
  • Table 361. MEA Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 362. MEA Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 363. MEA Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 364. MEA Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 365. Middle East Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 366. Middle East Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 367. Middle East Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 368. Middle East Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 369. Africa Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 370. Africa Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 371. Africa Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 372. Africa Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 373. North America Next Generation Pipettes, by Country USD Million (2022-2027)
  • Table 374. North America Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 375. North America Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 376. North America Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 377. North America Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 378. United States Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 379. United States Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 380. United States Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 381. United States Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 382. Canada Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 383. Canada Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 384. Canada Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 385. Canada Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 386. Mexico Next Generation Pipettes, by Type USD Million (2022-2027)
  • Table 387. Mexico Next Generation Pipettes, by Application USD Million (2022-2027)
  • Table 388. Mexico Next Generation Pipettes, by Distribution Channel USD Million (2022-2027)
  • Table 389. Mexico Next Generation Pipettes, by End-User USD Million (2022-2027)
  • Table 390. Next Generation Pipettes Sales: by Type(K Units)
  • Table 391. Next Generation Pipettes Sales Automatic , by Region K Units (2022-2027)
  • Table 392. Next Generation Pipettes Sales Semiautomatic , by Region K Units (2022-2027)
  • Table 393. Next Generation Pipettes Sales Manual , by Region K Units (2022-2027)
  • Table 394. Next Generation Pipettes Sales: by Application(K Units)
  • Table 395. Next Generation Pipettes Sales Biological Field , by Region K Units (2022-2027)
  • Table 396. Next Generation Pipettes Sales Chemical Field , by Region K Units (2022-2027)
  • Table 397. Next Generation Pipettes Sales Medical Field , by Region K Units (2022-2027)
  • Table 398. Next Generation Pipettes Sales: by Distribution Channel(K Units)
  • Table 399. Next Generation Pipettes Sales Online , by Region K Units (2022-2027)
  • Table 400. Next Generation Pipettes Sales Offline , by Region K Units (2022-2027)
  • Table 401. Next Generation Pipettes Sales: by End-User(K Units)
  • Table 402. Next Generation Pipettes Sales Biotechnological Companies , by Region K Units (2022-2027)
  • Table 403. Next Generation Pipettes Sales Hospitals , by Region K Units (2022-2027)
  • Table 404. Next Generation Pipettes Sales Diagnostic Centers , by Region K Units (2022-2027)
  • Table 405. Next Generation Pipettes Sales Research Laboratories , by Region K Units (2022-2027)
  • Table 406. Next Generation Pipettes Sales Others , by Region K Units (2022-2027)
  • Table 407. South America Next Generation Pipettes Sales, by Country K Units (2022-2027)
  • Table 408. South America Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 409. South America Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 410. South America Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 411. South America Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 412. Brazil Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 413. Brazil Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 414. Brazil Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 415. Brazil Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 416. Argentina Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 417. Argentina Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 418. Argentina Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 419. Argentina Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 420. Rest of South America Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 421. Rest of South America Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 422. Rest of South America Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 423. Rest of South America Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 424. Asia Pacific Next Generation Pipettes Sales, by Country K Units (2022-2027)
  • Table 425. Asia Pacific Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 426. Asia Pacific Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 427. Asia Pacific Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 428. Asia Pacific Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 429. China Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 430. China Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 431. China Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 432. China Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 433. Japan Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 434. Japan Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 435. Japan Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 436. Japan Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 437. India Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 438. India Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 439. India Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 440. India Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 441. South Korea Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 442. South Korea Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 443. South Korea Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 444. South Korea Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 445. Taiwan Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 446. Taiwan Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 447. Taiwan Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 448. Taiwan Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 449. Australia Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 450. Australia Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 451. Australia Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 452. Australia Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 453. Rest of Asia-Pacific Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 454. Rest of Asia-Pacific Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 455. Rest of Asia-Pacific Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 456. Rest of Asia-Pacific Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 457. Europe Next Generation Pipettes Sales, by Country K Units (2022-2027)
  • Table 458. Europe Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 459. Europe Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 460. Europe Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 461. Europe Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 462. Germany Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 463. Germany Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 464. Germany Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 465. Germany Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 466. France Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 467. France Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 468. France Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 469. France Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 470. Italy Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 471. Italy Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 472. Italy Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 473. Italy Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 474. United Kingdom Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 475. United Kingdom Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 476. United Kingdom Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 477. United Kingdom Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 478. Netherlands Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 479. Netherlands Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 480. Netherlands Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 481. Netherlands Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 482. Rest of Europe Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 483. Rest of Europe Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 484. Rest of Europe Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 485. Rest of Europe Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 486. MEA Next Generation Pipettes Sales, by Country K Units (2022-2027)
  • Table 487. MEA Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 488. MEA Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 489. MEA Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 490. MEA Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 491. Middle East Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 492. Middle East Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 493. Middle East Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 494. Middle East Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 495. Africa Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 496. Africa Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 497. Africa Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 498. Africa Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 499. North America Next Generation Pipettes Sales, by Country K Units (2022-2027)
  • Table 500. North America Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 501. North America Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 502. North America Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 503. North America Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 504. United States Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 505. United States Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 506. United States Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 507. United States Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 508. Canada Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 509. Canada Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 510. Canada Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 511. Canada Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 512. Mexico Next Generation Pipettes Sales, by Type K Units (2022-2027)
  • Table 513. Mexico Next Generation Pipettes Sales, by Application K Units (2022-2027)
  • Table 514. Mexico Next Generation Pipettes Sales, by Distribution Channel K Units (2022-2027)
  • Table 515. Mexico Next Generation Pipettes Sales, by End-User K Units (2022-2027)
  • Table 516. Next Generation Pipettes: by Type(USD/Units)
  • Table 517. Research Programs/Design for This Report
  • Table 518. Key Data Information from Secondary Sources
  • Table 519. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Next Generation Pipettes: by Type USD Million (2016-2021)
  • Figure 5. Global Next Generation Pipettes: by Application USD Million (2016-2021)
  • Figure 6. Global Next Generation Pipettes: by Distribution Channel USD Million (2016-2021)
  • Figure 7. Global Next Generation Pipettes: by End-User USD Million (2016-2021)
  • Figure 8. South America Next Generation Pipettes Share (%), by Country
  • Figure 9. Asia Pacific Next Generation Pipettes Share (%), by Country
  • Figure 10. Europe Next Generation Pipettes Share (%), by Country
  • Figure 11. MEA Next Generation Pipettes Share (%), by Country
  • Figure 12. North America Next Generation Pipettes Share (%), by Country
  • Figure 13. Global Next Generation Pipettes: by Type K Units (2016-2021)
  • Figure 14. Global Next Generation Pipettes: by Application K Units (2016-2021)
  • Figure 15. Global Next Generation Pipettes: by Distribution Channel K Units (2016-2021)
  • Figure 16. Global Next Generation Pipettes: by End-User K Units (2016-2021)
  • Figure 17. South America Next Generation Pipettes Share (%), by Country
  • Figure 18. Asia Pacific Next Generation Pipettes Share (%), by Country
  • Figure 19. Europe Next Generation Pipettes Share (%), by Country
  • Figure 20. MEA Next Generation Pipettes Share (%), by Country
  • Figure 21. North America Next Generation Pipettes Share (%), by Country
  • Figure 22. Global Next Generation Pipettes: by Type USD/Units (2016-2021)
  • Figure 23. Global Next Generation Pipettes share by Players 2021 (%)
  • Figure 24. Global Next Generation Pipettes share by Players (Top 3) 2021(%)
  • Figure 25. Global Next Generation Pipettes share by Players (Top 5) 2021(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Danaher Corporation (United States) Revenue: by Geography 2021
  • Figure 29. Eppendorf AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Eppendorf AG (Germany) Revenue: by Geography 2021
  • Figure 31. Tecan Group Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Tecan Group Ltd. (Switzerland) Revenue: by Geography 2021
  • Figure 33. Gardner Denver Medical (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Gardner Denver Medical (Germany) Revenue: by Geography 2021
  • Figure 35. Mettler-Toledo International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Mettler-Toledo International Inc. (United States) Revenue: by Geography 2021
  • Figure 37. Hamilton Company (United States) Revenue, Net Income and Gross profit
  • Figure 38. Hamilton Company (United States) Revenue: by Geography 2021
  • Figure 39. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. PerkinElmer, Inc. (United States) Revenue: by Geography 2021
  • Figure 41. Sartorius AG (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Sartorius AG (Germany) Revenue: by Geography 2021
  • Figure 43. Gilson, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Gilson, Inc. (United States) Revenue: by Geography 2021
  • Figure 45. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Agilent Technologies, Inc. (United States) Revenue: by Geography 2021
  • Figure 47. Global Next Generation Pipettes: by Type USD Million (2022-2027)
  • Figure 48. Global Next Generation Pipettes: by Application USD Million (2022-2027)
  • Figure 49. Global Next Generation Pipettes: by Distribution Channel USD Million (2022-2027)
  • Figure 50. Global Next Generation Pipettes: by End-User USD Million (2022-2027)
  • Figure 51. South America Next Generation Pipettes Share (%), by Country
  • Figure 52. Asia Pacific Next Generation Pipettes Share (%), by Country
  • Figure 53. Europe Next Generation Pipettes Share (%), by Country
  • Figure 54. MEA Next Generation Pipettes Share (%), by Country
  • Figure 55. North America Next Generation Pipettes Share (%), by Country
  • Figure 56. Global Next Generation Pipettes: by Type K Units (2022-2027)
  • Figure 57. Global Next Generation Pipettes: by Application K Units (2022-2027)
  • Figure 58. Global Next Generation Pipettes: by Distribution Channel K Units (2022-2027)
  • Figure 59. Global Next Generation Pipettes: by End-User K Units (2022-2027)
  • Figure 60. South America Next Generation Pipettes Share (%), by Country
  • Figure 61. Asia Pacific Next Generation Pipettes Share (%), by Country
  • Figure 62. Europe Next Generation Pipettes Share (%), by Country
  • Figure 63. MEA Next Generation Pipettes Share (%), by Country
  • Figure 64. North America Next Generation Pipettes Share (%), by Country
  • Figure 65. Global Next Generation Pipettes: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Danaher Corporation (United States)
  • Eppendorf AG (Germany)
  • Tecan Group Ltd. (Switzerland)
  • Gardner Denver Medical (Germany)
  • Mettler-Toledo International Inc. (United States)
  • Hamilton Company (United States)
  • PerkinElmer, Inc. (United States)
  • Sartorius AG (Germany)
  • Gilson, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2021 210 Pages 59 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Next Generation Pipettes Market Quantitative research analysis
Global Next Generation Pipettes Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Next Generation Pipettes market are Danaher Corporation (United States), Eppendorf AG (Germany), Tecan Group Ltd. (Switzerland), Gardner Denver Medical (Germany), Mettler-Toledo International Inc. (United States), Hamilton Company (United States), PerkinElmer, Inc. (United States), Sartorius AG (Germany), Gilson, Inc. (United States) and Agilent Technologies, Inc. (United States).
In this highly competitive & fast evolving Next Generation Pipettes industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Biological Field, Chemical Field and Medical Field are the potential customers of Next Generation Pipettes industry.

Know More About Global Next Generation Pipettes Market Report?

Have a Query? Click Here

Other Related Reports

Temperature Capsule Comprehensive Study by Application (Healthcare/Medical, Sport & Fitness, Other), Components (Sensor, Data recorder, Software), Distribution Channel (Online, Offline) Players and R...
$ 3500
Pulmonology Device Comprehensive Study by Type (Pulmonary Biopsy Devices (Single- Use Biopsy Forceps, Brushes, Microbiology Brushes), Endobronchial Ultrasound (EBUS) Needles (Biopsy Needles, Transbro...
$ 3750
BRIC Diagnostic Imaging Equipment Comprehensive Study by Type (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, Mamography, Others), Application (Cardiology, Oncology, Neuro...
$ 3650
Fat Injection Guns Comprehensive Study by Application (Aesthetic (Facial Augmentation, Buttock Augmentation, Breast Augmentation, Hand Rejuvenation, Others), Reconstructive (Dermal Filling of Injury,...
$ 3750
Pipette Accuracy Tester Comprehensive Study by Application (Laboratory {Pharmaceutical, Biotechnology, Chemical, Forensic, Cosmetics, Food & Beverages}, Research Institutes), Category (Electronic, Me...
$ 3750
Ostomy Devices Comprehensive Study by Type (Bags, Accessories), End-users (Ambulatory Surgical Centers, Hospitals, Home Care, Others), Surgery Type (Ileostomy Drainage Bags, Colostomy Drainage Bags, ...
$ 3450